GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 2758
EU - Europa 2058
AS - Asia 247
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 4
SA - Sud America 3
Totale 5081
Nazione #
US - Stati Uniti d'America 2704
DE - Germania 828
IT - Italia 548
SE - Svezia 231
CN - Cina 181
GB - Regno Unito 124
UA - Ucraina 110
DK - Danimarca 58
CA - Canada 54
AT - Austria 37
VN - Vietnam 31
IE - Irlanda 29
BE - Belgio 20
FI - Finlandia 20
FR - Francia 19
RU - Federazione Russa 18
TR - Turchia 14
EU - Europa 11
IN - India 10
RS - Serbia 5
CH - Svizzera 4
HU - Ungheria 3
IR - Iran 3
JP - Giappone 3
MU - Mauritius 3
CL - Cile 2
KR - Corea 2
NL - Olanda 2
BG - Bulgaria 1
BR - Brasile 1
HK - Hong Kong 1
RO - Romania 1
SC - Seychelles 1
SG - Singapore 1
TW - Taiwan 1
Totale 5081
Città #
Ann Arbor 1312
Frankfurt am Main 734
Milan 276
Wilmington 243
Chandler 159
Fairfield 134
Dearborn 114
Jacksonville 97
Houston 91
Woodbridge 91
Ashburn 59
Princeton 57
Cambridge 46
Seattle 44
Mcallen 43
Vienna 35
Nanjing 30
Dublin 29
Guangzhou 24
Brussels 20
Altamura 18
Lachine 17
Lawrence 16
Ottawa 16
Segrate 13
Shenyang 13
Shanghai 12
Boardman 11
Nanchang 11
Beijing 10
Kunming 10
Sacramento 10
San Diego 10
Toronto 10
Turin 10
Auburn Hills 9
Dong Ket 9
Edmonton 9
Lissone 9
Monza 9
Zhengzhou 9
Hebei 8
London 8
Tianjin 8
Changsha 7
Fremont 6
Jiaxing 6
Jinan 6
Council Bluffs 5
Halle 5
Los Angeles 5
Napoli 5
Taizhou 5
Andover 4
Bergamo 4
Gavirate 4
Hangzhou 4
Kiev 4
Norwalk 4
Philadelphia 4
Rieti 4
San Mateo 4
Siena 4
Asti 3
Bologna 3
Budapest 3
Chions 3
Falls Church 3
Hanoi 3
Magnago 3
Ningbo 3
Padova 3
Pavia 3
Rome 3
Annone di Brianza 2
Bovisio Masciago 2
Cambiago 2
Cermenate 2
Chicago 2
Como 2
Daejeon 2
Fano 2
Gallarate 2
Hefei 2
Montréal 2
Nürnberg 2
Phoenix 2
Pomigliano d'Arco 2
San Fili 2
San Rocco 2
Shaoxing 2
Verona 2
Villa Cortese 2
Aarhus 1
Anaheim 1
Ardabil 1
Arezzo 1
Bari 1
Boston 1
Brescia 1
Totale 4071
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 478
Combinations of a btk inhibitor and fluorouracil for treating cancers 443
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 427
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 404
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 367
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 329
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 329
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 280
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 267
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 255
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 232
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 168
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 153
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 142
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 125
Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours 121
Isoform of bruton's tyrosine kinase (BTK) protein 118
Isoform of Bruton's tyrosine kinase (BTK) protein 114
Modulator compounds of the drug resistance in epithelial tumour cells 112
Isoform of bruton's tyrosine kinase (BTK) protein 110
Modulator compounds of the drug resistance in epithelial tumour cells 109
Modulator compounds of the drug resistance in epithelial tumour cells 95
NEW ISOFORM OF BRUTON’S TYROSINE KINASE (BTK) PROTEIN 93
Modulator compound of the drug resistance in epithelial tumor cells 73
Emerging actionable targets to treat therapy-resistant colorectal cancers 61
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 55
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression 54
Identifying novel actionable targets in colon cancer 45
Editorial: Targeting Bruton Tyrosine Kinase 40
BTK, the new kid on the (oncology) block? 23
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 12
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 8
Totale 5642
Categoria #
all - tutte 8429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201811 0000 00 00 00011
2018/2019361 3316125 1234 3539 41462563
2019/20201067 78628772 95130 13685 10310510212
2020/20211359 6729135128 122135 134139 11014598117
2021/2022639 90839657 2440 2516 18127999
2022/20231371 126288145115 85142 88108 102738316
Totale 5642